Search all trials

Find therapies in clinical trials near you – page 30

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Chronic lymphocytic leukaemia+1

Not recruiting

InvestigationalNo placebo

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Essential thrombocythaemia+1

Not recruiting

Registered drugNo placebo

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ropeginterferon Alfa-2B

Contact Research Centre

Acute myocardial infarction

Not recruiting

Registered drug

Study to Test BI 765845 for Patients with Heart Attack

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Bi 765845

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myocardial infarction+5

Not recruiting

Investigational

Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Zalunfiban

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Pomalidomide

Contact Research Centre

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Not recruiting

Registered drugNo placebo

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Aminocaproic Acid

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Baricitinib

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Bemcentinib

Contact Research Centre

Find therapies in clinical trials near you – page 30

390 trials match your criteria

Myelodysplastic syndrome

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Chronic lymphocytic leukaemia+1

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

Essential thrombocythaemia+1

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Acute myocardial infarction

Study to Test BI 765845 for Patients with Heart Attack

Plasma cell myeloma

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Myelodysplastic syndrome

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Acute myocardial infarction+5

Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

Acute myeloid leukaemia

Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

Plasma cell myeloma

Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Lung disorder

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.